New heart device aims to quiet chest pain in Hard-to-Treat condition

NCT ID NCT06991322

Recruiting now Symptom relief Sponsor: VahatiCor, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the A-FLUX Coronary Sinus Reducer to see if it can safely improve chest pain or discomfort in people with coronary microvascular dysfunction (CMD), a condition where tiny heart vessels don't work properly. About 30 adults with persistent symptoms despite standard treatments will receive the device. The goal is to check if the device can be placed safely and help reduce symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY MICROVASCULAR DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary microvascular disorder Microvascular Angina

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY MICROVASCULAR DISEASE CORONARY MICROVASCULAR DYSFUNCTION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Clínic Barcelona
RECRUITING

Barcelona, Spain

Contact
University Medical Center Utrecht
RECRUITING

Utrecht, 3584, Netherlands

Contact
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu
RECRUITING

Warsaw, Poland

Contact